Ligand Pharmaceuticals | LGND - Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
Agenus USD 14.67M 1.35M 2026-03
Amgen USD 653M 94.99B 2026-09
Anika Therapeutics 183.47M 4.09M 2026-06
Arrowhead Research USD 24.56M 716K 2026-06
Baxter International USD 64M 14M 2026-06
Bristol-Myers Squibb USD 403M 4M 2026-09
Eli Lilly USD 316M 201.3M 2026-09
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Enviri Corporation USD 28.44M 1.74M 2025-12
Gilead Sciences USD 269M 22M 2026-09
GlaxoSmithKline GBP 219M 98M 2026-09
Glaxosmithkline GBP 264.74M 72.01M 2026-09
Heron Therapeutics USD 600K 100K 2024-12
Insmed USD 20.41M 1.57M 2026-09
Intrexon USD 2K 5K 2024-06
Ionis Pharmaceuticals USD 18M 1000K 2026-06
Karyopharm Therapeutics USD 12.55M 66K 2026-03
Ligand Pharmaceuticals USD 1.78M 875K 2025-12
MacroGenics USD 4.4M 493K 2026-06
Merck USD 525M 46M 2026-06
Pacira USD 112.4M 108.78M 2026-09
Pfizer USD 662M 5M 2026-09
Rigel Pharmaceuticals USD 2.06M 31K 2024-09
Sangamo BioSciences 97.56M 11.39M 2025-06
Veracyte USD 2K 1000 2023-12